IBA Molecular, Piramal in F-18 amyloid imaging agent manufacturing agreement
06:04 EDT 7 Aug 2012 | Medical Business Review
IBA Molecular has entered into an agreement to manufacture and distribute Piramal's new diagnostic imaging agent, 18F-Florbetaben, in the US and Europe.
Original Article: IBA Molecular, Piramal in F-18 amyloid imaging agent manufacturing agreement
More From BioPortfolio on "IBA Molecular, Piramal in F-18 amyloid imaging agent manufacturing agreement"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
